ACADL and metabolic dysfunction-associated steatohepatitis: One possibility is that FAO in patients with advanced-stage NASH may be impaired in the process of acyl-CoA dehydrogenation that is catalyzed by acyl-CoA dehydrogenases including very long-chain acyl-CoA dehydrogenase (VLCAD), long-chain acyl-CoA dehydrogenase (LCAD), and medium-chain acyl-CoA dehydrogenase (MCAD).